Dme Capital Management, LP Liva Nova PLC Transaction History
Dme Capital Management, LP
- $2.4 Trillion
- Q3 2024
A detailed history of Dme Capital Management, LP transactions in Liva Nova PLC stock. As of the latest transaction made, Dme Capital Management, LP holds 603,549 shares of LIVN stock, worth $28.2 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
603,549
Previous 644,269
6.32%
Holding current value
$28.2 Million
Previous $35.3 Billion
10.22%
% of portfolio
1.32%
Previous 1.73%
Shares
3 transactions
Others Institutions Holding LIVN
# of Institutions
261Shares Held
52.9MCall Options Held
316KPut Options Held
127K-
Black Rock Inc. New York, NY6.9MShares$323 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.63MShares$263 Million0.22% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.96MShares$138 Million0.08% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.09MShares$97.8 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$97.5 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.5B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...